Fundraising FoxChroma Medicine
Boston, US · Founded 2020 · 6 known investors
Find your way into Chroma Medicine
Sign up to see every warm intro you have to Chroma Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chroma Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
nChroma Bio is a genetic medicines company developing in vivo therapies that pair genetic cargoes with targeted delivery technologies. It takes a disease-first approach, designing durable treatments aimed at the biological drivers of diseases with high unmet need.
Founders & leadership
Investors · 6
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements▶$135MraisedSep 2023 · 21 investors · BiotechnologyRule 506(b)
- BIHUA CHENDirector
- GEORGE GOLUMBESKIDirector
- KEVIN BITTERMANDirector
- BRETT KAPLANExecutive Officer
- VIC MYERExecutive Officer
- MICHAEL KELLYDirector
- CATHERINE STEHMAN-BREENExecutive Officer, Director
- PAOLA POZZIDirector
- JEFF MARRAZZODirector
- THOMAS CAHILLDirector
- Offering amount
- $135M
- Amount sold
- $135M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Chroma Medicine do?
- nChroma Bio is a genetic medicines company developing in vivo therapies that pair genetic cargoes with targeted delivery technologies. It takes a disease-first approach, designing durable treatments aimed at the biological drivers of diseases with high unmet need.
- Who are Chroma Medicine's investors?
- Chroma Medicine's investors include OUP (Osage University Partners), Wellington Management, Atlas Venture, Casdin Capital, GV (Google Ventures), Newpath Partners.
- Where is Chroma Medicine headquartered?
- Chroma Medicine is headquartered in Boston, US.